COMPANY

Pelagos Pharmaceuticals, Inc.

HQ: Houston, TX source · pelagospharma.com ↗ · Southwest

Keywords: From press sources:neurology Alzheimer's disease small molecule

Location: Houston, TX · source · Oct 15, 2026

Profile checked Oct 10, 2026

NIH awards 2

Annual award amounts. Total $540K.

Jul 25, 2023 NIH award 3R41AG079778-01A1S1 FY2023: $90,950 awarded for that fiscal year; activity R41 (STTR); PI CRESAP, MICHELE; recipient as written: PELAGOS PHARMACEUTICALS, INC., HOUSTON, TX. Developing Novel REV-ERB Agonists source ↗
Aug 16, 2022 NIH award 1R41AG079778-01A1 FY2022: $449,482 awarded for that fiscal year; activity R41 (STTR); PI CRESAP, MICHELE; recipient as written: PELAGOS PHARMACEUTICALS, INC., HOUSTON, TX. Developing Novel REV-ERB Agonists source ↗